In letters posted on Truth Social, Trump demanded that drugmakers offer their medications at the same prices paid abroad.

Trump posted individual letters he sent 17 drugmakers, including Eli Lilly, GSK, Pfizer, Regeneron, Merck, Pfizer and Novo ...

U.S. President Donald Trump sent letters to the chief executives of 17 major pharmaceutical companies, urging immediate ...

President Trump urges top pharmaceutical firms to lower U.S. drug prices under his most-favored-nation drug pricing policy ...

President Donald Trump is ratcheting up the pressure on major drugmakers to bring their US prices in line with the far lower ...

In 17 identical letters posted to his Truth Social account, the president said companies must lower their prices or the ...

U.S. President Donald Trump on Thursday sent 17 letters to pharmaceutical companies' CEOs in an attempt to pressure them to lower drug prices within 60 days, threatening to take action if they refuse ...

In the letters, sent to Eli Lilly & Co., Novo Nordisk A/S, Pfizer Inc. and others, Trump insisted companies immediately lower ...

Trump gave the companies 60 days to voluntarily comply, threatening to "deploy every tool in our arsenal to protect American ...

Retail buzz around major pharmaceutical stocks jumped Thursday, with sentiment turning bullish across most major drugmakers, ...

Both Eli Lilly LLY and Merck MRK are major players in the U.S. pharmaceutical industry, developing and commercializing therapies across oncology, immunology, and diabetes and cardiovascular areas.

Eli Lilly’s experimental cholesterol drug doubled patients’ HDL, or good cholesterol, setting the stage for a race between the Indianapolis pharmaceutical company and Merck and Roche Holding ...